ENVBConference•businesswire•
Enveric Biosciences Announces Participation in 2025 BIO International Convention
Sentiment:Neutral (50)
Summary
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of psychiatric and neurological disorders, today announced that the company is participating in the BIO International Convention being held June 16-19, 2025, in Boston, Massachusetts. During the conference, CEO and Director of Enveric, Joseph Tucker, Ph.D., will conduct one
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 16, 2025 by businesswire